AJ MEDICAL ENTERPRISE LTD
Opportunity 74/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (78/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2025-06-29 | 2024-06-29 |
|---|---|---|
| Average employees | 100 | 100 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 accounts
- • 1 accounts
- • 1 accounts
Corporate timeline (22 events)Click to expand
- 2026-06-19📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2025-06-20📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-06-27📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-06-29📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2022-04-26📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2021-09-29📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2021-06-29📄change-account-reference-date-company-current-shortenedaccounts · AA01
- 2020-07-02📄appoint-person-secretary-company-with-name-dateofficers · AP03
- 2020-07-02📄termination-secretary-company-with-name-termination-dateofficers · TM02
- 2020-07-02📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2020-06-30📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2020-06-20➕AKHTAR, Rehana appointedsecretary
- 2020-06-20➖IMRAN, Aalia resignedsecretary
- 2019-03-28📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2018-06-30📄gazette-filings-brought-up-to-dategazette · DISS40
- 2018-06-28📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2018-06-05📄gazette-notice-compulsorygazette · GAZ1
- 2017-10-17📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2017-10-17📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC01
- 2014-06-19🏢Company incorporatedAs AJ MEDICAL ENTERPRISE LTD
- 2014-06-19➕JABBAR, Adnan, Dr appointeddirector
- 2014-06-19➕IMRAN, Aalia appointedsecretary
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Sole director: Only one active director — all governance concentrated on one person.
Succession & seller-readiness
Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
- secondary12+ year tenure: Director in role 12 years.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr Adnan Jabbar Individual · British · DOB 11/1983 · age 43 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 06/04/2016 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · WF postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| ADAM&ANAS MEDICAL LTD→ 16488324 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ADHD IN MIND LTD→ 16698556 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ADVANCE DENTAL CLINIC LIMITED→ 06907447 · est 2009 · no financials extracted | — | — | — | — | 16y | — | — |
| AESTHETICS AND WELLNESS LTD→ 14411959 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| AH HEALTH RESOURCES LTD→ 15186536 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AHMAD HEALTHCARE LIMITED→ 10931011 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| AHMED MEDICAL SERVICES LTD→ 17002813 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| AHN ENTERPRISE LTD→ 11761752 · est 2019 · no financials extracted | — | — | — | — | 7y | — | — |
| AHN HEALTHCARE LTD→ 11132120 · est 2018 · no financials extracted | — | — | — | — | 8y | — | — |
| AJAY GUPTA LIMITED→ 15056713 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AKHTAR PHARM LIMITED→ 16090065 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| AKJEM HEALTHCARE SERVICES LTD→ 15121481 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 1 resigned)
Click a director name to see their full track record across all companies.